adjust ep exclud certain amort restructur one-tim item
zoeti locat parsippani nj world largest anim health compani medicin product
octob zoeti announc ceo juan ramn alaix retir end succeed
kristin peck current serv presid us oper busi develop strategi
impress run ceo juan ramn alaix tenur ceo one impress
healthcar past year sinc zoeti went public februari mark consist
revenu growth oper execut margin expans nearli return ipo price vs
return less familiar kristin peck credibl mr alaix earn
tenur give us confid successor
solid foot ceo transit come time strength zoeti particularli within companion
anim portfolio head us oper sinc kristin peck overseen growth blockbust
product like apoquel cytopoint simparica busi develop side led sinc
also play lead role acquisit abaxi experi import sinc view
launch simparica trio expans abaxi platform two signific new growth driver
compani next sever year
increas estim also use opportun rais estim beyond base
increas expect simparica trio growth altern channel expect adjust ep
previous grow previous per share
continu recommend investor hold base valuat confid compani abil
expand leadership posit anim health market unchang announc ceo transit zoeti
great invest sharehold sinc becom public compani expect continu howev
ignor fact share trade ebitda estim billion ep
multipl repres approxim premium nearest competitor zoeti certainli
deserv premium multipl magnitud premium leav littl margin error expect
simparica trio continu grow trade premium pmv per share
million except per share
exclud certain non-cash item restructur certain one-tim item
compani file research estim
million except per share
current market discount pmv
after-tax payment buy option pmv
compani file research estim
kevin kedra research analyst prepar report herebi certifi view express report accur reflect
analyst person view subject compani secur research analyst receiv
direct indirect compens express specif recommend view report
public data august rate buy
chang hold may
